Copyright
©2007 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 21, 2007; 13(43): 5760-5764
Published online Nov 21, 2007. doi: 10.3748/wjg.v13.i43.5760
Published online Nov 21, 2007. doi: 10.3748/wjg.v13.i43.5760
Table 1 Characteristics of patients and controls n (%)
Characteristic | Patients n = 191 | Controls n = 198 | P1 | OR (95% CI)2 |
Age (yr) | ||||
< 50 | 28 (14.7) | 84 (42.9) | ||
50-64 | 118 (61.7) | 67 (33.4) | P < 0.001 | - |
≥ 65 | 45 (23.6) | 47 (23.7) | ||
Mean age (SD) | 58.3 (8.3) | 52.8 (13.2) | - | - |
Sex | ||||
Male | 126 (66.0) | 122 (61.6) | P = 0.372 | - |
Female | 65 (34.0) | 76 (38.4) | - | |
Smoking status | ||||
Non-smokers3 | 75 (39.3) | 121 (61.1) | P < 0.001 | 1.00 (References) |
Current smokers | 116 (60.7) | 77 (38.9) | 3.76 (2.01-6.73) | |
Alcohol drinking status | ||||
Non-drinkers4 | 80 (41.9) | 128 (64.7) | 1.00 (References) | |
Current alcohol drinkers | 111 (58.1) | 70 (35.3) | P < 0.001 | 3.16 (1.91-5.24) |
Table 2 ADH2, ALDH2 genotype and allele frequencies and ORs for esophageal cancer n (%)
ADH2 | Cases (n = 191) | Controls (n = 198) | OR (95% CI)1 |
*2/*2 | 78 (40.8) | 100 (50.5) | 1.00 (Reference) |
*1/*2 | 80 (41.9) | 76 (38.4) | 1.89 (1.10-3.22) |
*1/*1 | 33 (17.3) | 22 (11.1) | 1.91 (0.92-3.95) |
*1/*2 + *1/*1 | 113 (59.2) | 98 (49.5) | 1.65 (1.02-2.68) |
ALDH2 | |||
*1/*1 | 90 (47.1) | 108 (54.5) | 1.00 (References) |
*1/*2 | 98 (51.3) | 76 (38.4) | 1.67 (1.02-2.72) |
*2/*2 | 3 (1.6) | 14 (7.1) | 0.26 (0.06-1.09) |
*1/*2 + *2/*2 | 101 (52.9) | 90 (45.5) | 1.43 (0.89-2.30) |
Allele frequencies | OR (95% CI)2 | ||
ADH2 | |||
*2 | 236 (61.8) | 276 (69.7) | 1.00 (References) |
*1 | 146 (38.2) | 120 (30.3) | 1.42 (1.06-1.92) |
ALDH2 | |||
*1 | 278 (72.8) | 292 (73.7) | 1.00 (References) |
*2 | 104 (27.2) | 104 (26.3) | 1.05 (0.76-1.44) |
Table 3 Combined effect of alcohol consumption and ADH2 and ALDH2 polymorphisms on esophageal cancer n (%)
ADH2 | Alcohol drinking status | ||||||
Non-drinkers2 | Current alcohol drinkers | ||||||
Cases (n = 80) | Controls (n = 128) | OR (95% CI)1 | Cases (n = 111) | Controls (n = 70) | OR (95% CI)1 | ||
*2/*2 | 37 (46.3) | 65 (50.8) | 1.00 (References) | 41 (36.9) | 35 (50.0) | 1.88 (0.86-4.15) | |
*1/*2 or *1/*1 | 43 (53.7) | 63 (49.2) | 1.21 (0.63-2.33) | 70 (63.1) | 35 (50.0) | 3.94 (1.76-8.81) | |
ALDH2 | |||||||
*1/*1 | 33 (41.3) | 67 (52.3) | 1.00 (References) | 57 (51.4) | 41 (58.6) | 3.15 (1.39-7.13) | |
*1/*2 or *2/*2 | 47 (58.7) | 61 (47.7) | 2.03 (1.03-3.99) | 54 (48.6) | 29 (41.4) | 4.82 (2.06-11.27) | |
ADH2 and ALDH2 | |||||||
*2/*2 | *1/*1 | 15 (18.8) | 42 (32.8) | 1.00 (References) | 17 (15.3) | 20 (28.6) | 2.54 (0.84-7.67) |
*1/*2 or *1/*1 | *1/*2 or *2/*2 | 25 (31.3) | 38 (29.7) | 2.46 (0.98-6.14) | 30 (27.0) | 14 (20.0) | 9.86 (3.10-31.38) |
-
Citation: Yang SJ, Wang HY, Li XQ, Du HZ, Zheng CJ, Chen HG, Mu XY, Yang CX. Genetic polymorphisms of
ADH2 andALDH2 association with esophageal cancer risk in southwest China. World J Gastroenterol 2007; 13(43): 5760-5764 - URL: https://www.wjgnet.com/1007-9327/full/v13/i43/5760.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i43.5760